Corina Becker

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Topics

Placebo Controlled

Top Venues

Clinical pharmacokinetics

American journal of cardiovascular drugs : drugs, devices, and other interventions

Clinical and translational science

European journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Boettcher, Corina Becker
Authors' Reply to Ganijee et al.: "Comment on: Evaluation of the Influence of Sildenafil on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults". Clinical pharmacokinetics (2023)
Hauke Ruehs, Alexander Solms, Matthias Frei, Corina Becker, Maria E Trujillo, Dirk Garmann, Michaela Meyer
Assessing QTc Effects of Vericiguat Using Two Different Concentration-QTc Modeling Approaches. Clinical pharmacokinetics (2023)
Michael Boettcher, Bettina Nowotny, Robert Krausche, Corina Becker
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults. Clinical pharmacokinetics (2023)
Michael Böttcher, Hans-Dirk Düngen, Vasile Corcea, Frank Donath, Rainard Fuhr, Pim Gal, Gerd Mikus, Dietmar Trenk, Martin Coenen, Philippe Vieira Pires, Claudia Maschke, Antonios Othon Aliprantis, Nina Besche, Corina Becker
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes. American journal of cardiovascular drugs : drugs, devices, and other interventions 23 (2) (2023)
Michael Boettcher, Bettina Nowotny, Robert Krausche, Corina Becker
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults. Clinical pharmacokinetics 62 (2) (2023)
Michael Böttcher, Hans-Dirk Düngen, Vasile Corcea, Frank Donath, Rainard Fuhr, Pim Gal, Gerd Mikus, Dietmar Trenk, Martin Coenen, Philippe Vieira Pires, Claudia Maschke, Antonios Othon Aliprantis, Nina Besche, Corina Becker
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes. American journal of cardiovascular drugs : drugs, devices, and other interventions 23 (2) (2023)
Michael Boettcher, Bettina Nowotny, Robert Krausche, Corina Becker
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults. Clinical pharmacokinetics 62 (2) (2023)
Michael Boettcher, Bettina Nowotny, Robert Krausche, Corina Becker
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults. Clinical pharmacokinetics 62 (2) (2023)
Michael Böttcher, Hans-Dirk Düngen, Vasile Corcea, Frank Donath, Rainard Fuhr, Pim Gal, Gerd Mikus, Dietmar Trenk, Martin Coenen, Philippe Vieira Pires, Claudia Maschke, Antonios Othon Aliprantis, Nina Besche, Corina Becker
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes. American journal of cardiovascular drugs : drugs, devices, and other interventions (2023)
Michael Boettcher, Bettina Nowotny, Robert Krausche, Corina Becker
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults. Clinical pharmacokinetics 62 (2) (2023)
Michael Böttcher, Hans-Dirk Düngen, Vasile Corcea, Frank Donath, Rainard Fuhr, Pim Gal, Gerd Mikus, Dietmar Trenk, Martin Coenen, Philippe Vieira Pires, Claudia Maschke, Antonios Othon Aliprantis, Nina Besche, Corina Becker
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes. American journal of cardiovascular drugs : drugs, devices, and other interventions 23 (2) (2023)
Michael Böttcher, Hans-Dirk Düngen, Vasile Corcea, Frank Donath, Rainard Fuhr, Pim Gal, Gerd Mikus, Dietmar Trenk, Martin Coenen, Philippe Vieira Pires, Claudia Maschke, Antonios Othon Aliprantis, Nina Besche, Corina Becker
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes. American journal of cardiovascular drugs : drugs, devices, and other interventions 23 (2) (2023)
Michael Boettcher, Gerd Mikus, Dietmar Trenk, Hans-Dirk Düngen, Frank Donath, Nikos Werner, Mahir Karakas, Nina Besche, Dominik Schulz-Burck, Mireille Gerrits, James Hung, Corina Becker
Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR study. Clinical and translational science 15 (5) (2022)
Michael Boettcher, Dirk Thomas, Wolfgang Mueck, Stephanie Loewen, Erich Arens, Kenichi Yoshikawa, Corina Becker
Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects. European journal of clinical pharmacology 77 (4) (2020)